Navigation Links
PharmAthene to Host Third Quarter 2010 Conference Call and Webcast on Thursday, November 11, 2010
Date:11/4/2010

ANNAPOLIS, Md., Nov. 4, 2010 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex: PIP) a biodefense company developing medical countermeasures against biological and chemical threats, announced today that its financial results for the third quarter of 2010 will be released on Thursday, November 11, 2010.

PharmAthene management will be hosting a conference call to discuss the Company's third quarter 2010 financial results.  The call is scheduled to begin at 4:30 p.m. Eastern Time on Thursday, November 11, 2010, and is expected to last approximately 30 minutes.

The dial-in number within the United States is 800-299-0148.  The dial-in number for international callers is 617-801-9711.  The participant passcode is 56373544.

A replay of the conference call will be available beginning at approximately 7:30 p.m. Eastern Time on November 11, 2010 until approximately 11:59 p.m. Eastern Time on December 11, 2010.  The dial-in number to access the reply from within the United States is 888-286-8010.   For international callers, the dial-in number is 617-801-6888.  The participant passcode is 23749330.

The conference call will also be webcast and can be accessed from the company's website at www.PharmAthene.com.  A link to the webcast may be found under the Investor Relations section of the website.  

Contact:  

Stacey Jurchison

PharmAthene, Inc.

Phone: 410-269-2610

Stacey.Jurchison@PharmAthene.com


'/>"/>
SOURCE PharmAthene, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. PharmAthene to Webcast its Third Quarter Conference Call on November 13, 2007 at 4:30 P.M. Eastern Time
2. PharmAthenes Recombinant Butyrylcholinesterase (rBChE) May Play A Neuroprotective Role in Alzheimers Disease
3. PharmAthene Presents Data for Protexia(R) and Valortim(R) at 2008 BARDA Industry Conference / PHEMCE Stakeholders Workshop
4. PharmAthene Initiates Phase I Clinical Trial of Nerve Agent Bioscavenger Protexia(R)
5. PharmAthene to Host a Conference Call and Webcast on Wednesday, April 29th at 4:30 PM to Provide an Update on the SparVax(TM) rPA Anthrax Vaccine Program
6. PharmAthene Submits SparVax(TM) Regulatory Strategy to FDA
7. PharmAthene Submits Proposal to BARDA in Response to Broad Agency Announcement for Advanced Research and Development for Valortim(R)
8. PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop
9. PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop
10. PharmAthene Develops Thermostable Lyophilized rPA Anthrax Vaccine Under a Challenge Grant From the National Institutes of Health
11. PharmAthene Presents New Data for Lyophilized rPA Anthrax Vaccine Showing Enhanced Immunogenicity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2015)... FOREST, Ill. , March 6, 2015   Hospira, ... the U.S. Food and Drug Administration (FDA) on today,s FDA ... States . This is a watershed moment for improving ... As a leading global provider of biosimilars, Hospira has seen ... we are a proud participant in these early stages of ...
(Date:3/6/2015)... , March 6, 2015  Abaxis, Inc. (NasdaqGS: ... point-of-care instruments and consumables for the medical, research, and ... the veterinary and research markets in the ... for Veterinary Biologicals of the U.S. Department of Agriculture ... for the detection of   A. phagocytophelium and ...
(Date:3/6/2015)... , March 6, 2015   Veracyte, Inc. ... data demonstrating that diagnostic tests that use increasing numbers ... dramatically reduce the specificity of test results, leading to ... are erroneously diagnosed as cancerous. In addition, these new ... of the malignancies leading to "false negatives." The data ...
Breaking Medicine Technology:Hospira Statement on FDA Approval of the First Biosimilar in the United States 2Hospira Statement on FDA Approval of the First Biosimilar in the United States 3Abaxis, Inc. Announces USDA Clearance of VetScan Anaplasma Rapid Test 2Abaxis, Inc. Announces USDA Clearance of VetScan Anaplasma Rapid Test 3Veracyte Announces New Data that Inform Optimal Use of Molecular Testing in Preoperative Thyroid Nodule Assessment 2Veracyte Announces New Data that Inform Optimal Use of Molecular Testing in Preoperative Thyroid Nodule Assessment 3Veracyte Announces New Data that Inform Optimal Use of Molecular Testing in Preoperative Thyroid Nodule Assessment 4Veracyte Announces New Data that Inform Optimal Use of Molecular Testing in Preoperative Thyroid Nodule Assessment 5Veracyte Announces New Data that Inform Optimal Use of Molecular Testing in Preoperative Thyroid Nodule Assessment 6
... The American Pharmacists Association would like to remind ... pharmacist during cold and flu season. A pharmacist can ... shot, identifying the differences between a common cold and ... a recommendation when a health care provider should be ...
... LAKE ZURICH, Ill. and HACKENSACK, N.J., Jan. 18, 2011 ... of Hackensack, N.J., announced today they have signed an ... range of Genesis-branded products for blood centers, plasma centers ... The agreement covers products such as Genesis™ blood ...
Cached Medicine Technology:Pharmacists Offer Recommendations to Guide Public Through Cold and Flu Season 2Pharmacists Offer Recommendations to Guide Public Through Cold and Flu Season 3Fenwal, GenesisBPS Enter Agreement for Blood-Specialty Products 2
(Date:3/6/2015)... (PRWEB) March 06, 2015 Follow ... of the most common forms of cancer and is ... cancer can be screened through various techniques and tools, ... however remains the gold standard technique in breast cancer ... cost, time taken for the procedure, required expertise to ...
(Date:3/6/2015)... 2015 Ticket Down is a reputable source ... exchange has extended their customer appreciation discount code ED-SHEERAN-2015 for ... Yorkshire England and he began his career in the music ... couple of years Ed Sheeran has become a household name. ... on stage he is having the time of his life ...
(Date:3/6/2015)... Further solidifying their position as a ... announced today that the company has earned Inavero’s Best ... of Staffing Talent Award five years in a row. ... Talent Diamond winners are proven industry leaders in service ... the individuals they have helped find temporary and permanent ...
(Date:3/6/2015)... Since Medicare began paying for chronic ... been an overwhelming demand from providers for straightforward guidance ... program. The Centers for Medicare & Medicaid Services ... PYA’s updated white paper—“ Providing and Billing Medicare for ... detailed, yet practical “how to” manual for providers looking ...
(Date:3/6/2015)... Magellan Rx Management’s 2014 Medical Pharmacy Trend Report ... and statistics on one of the nation’s biggest drivers ... Management will discuss key findings from the report in ... Spend,” a complimentary March 19 webinar, managed and moderated ... makes up more than a quarter of total drug ...
Breaking Medicine News(10 mins):Health News:Rising Popularity of 3D Mammography Drives the Global Mammography Equipment Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Rising Popularity of 3D Mammography Drives the Global Mammography Equipment Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:Ed Sheeran Tickets in Indianapolis, Austin, Albany, St. Louis, London, Des Moines, Salt Lake City, Saskatoon, Regina and Denver/Morrison Now On Sale at Ticket Down 2Health News:Cross Country Healthcare: Medical Doctor Associates Earns Inavero's 2015 Best of Staffing Talent Diamond Award 2Health News:Cross Country Healthcare: Medical Doctor Associates Earns Inavero's 2015 Best of Staffing Talent Diamond Award 3Health News:Updated PYA White Paper Meets Demand for Guidance on Providing and Billing Medicare for Chronic Care Management 2Health News:Atlantic Information Services, Magellan Rx Management Partner on Complimentary Webinar Outlining Key Findings of New Medical Pharmacy Trend Report 2
... with a low prevalence of tuberculosis (TB), the majority ... the U.S for the diagnosis of TB are ... "We compared commercially available tests for latent tuberculosis infection ... prevalence," said James Mancuso, MD, DrPH, of the Walter ...
... , THURSDAY, Dec. 8 (HealthDay News) -- Increased consumption ... of breast cancer recurrence, new research finds. Researcher ... University of California, San Diego, looked at changes in ... potatoes, that breast cancer survivors ate over a one-year ...
... By Kathleen Doheny HealthDay Reporter , ... breast reconstruction after a mastectomy, despite the known cosmetic ... immediate reconstruction rates are higher in women with DCIS ... with invasive cancer," said Dr. Dawn Hershman, an associate ...
... ANTONIO -- Precisely quantifying the amount of three different ... linked to breast cancer , did not predict ... Cancer with Herceptin, say Mayo Clinic researchers. HER2-positive ... human epidermal growth factor receptor 2 that promotes cancer ...
... , THURSDAY, Dec. 8 (HealthDay News) -- New ... States should significantly shorten and simplify the course of the ... the U.S. Centers for Disease Control and Prevention. The ... -- which are based on expert opinion and the results ...
... HealthDay Reporter , THURSDAY, Dec. 8 (HealthDay News) -- ... about 22 percent in people with prehypertension who took drugs ... high blood pressure, but they still benefited from taking the ... of heart attacks for people taking antihypertensives. "We know ...
Cached Medicine News:Health News:Discordance among commercially-available diagnostics for latent TB infection 2Health News:Starchy Foods May Boost Risk of Breast Cancer Recurrence 2Health News:Starchy Foods May Boost Risk of Breast Cancer Recurrence 3Health News:Few Women Get Breast Reconstruction After Mastectomy: Study 2Health News:Few Women Get Breast Reconstruction After Mastectomy: Study 3Health News:Proteins do not predict outcome of herceptin treatment in HER2-positive breast cancer 2Health News:CDC Issues New TB Treatment Guidelines 2Health News:Treating Prehypertension Lowers Stroke Risk: Study 2Health News:Treating Prehypertension Lowers Stroke Risk: Study 3
The NPT7 blood gas analyzer measures pH/blood gases and oximetry on 90 L sample volume with a two-step sampling procedure. Clinical tests compare NPT7 accuracy to that of benchtop analyzers. 30 sampl...
... GEM Premier 3000 simplifies and ... addition to unique features such ... and comprehensive menu options, the ... Intelligent Quality Management (iQM), an ...
... IRMA TRUpoint sets the standard for ... chemistries right at your patient's side ... This powerful, self contained system can ... CCU to ICU, or wherever you ...
Mini-flatbed agitator....
Medicine Products: